Pharmaceutical Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X
Analysis

Verge Genomics: employing AI to improve drug discovery

Verge Genomics has successfully seized the immense opportunities from AI and machine learning algorithms to revolutionise drug discovery processes for the largely unmet medical need of neurodegenerative diseases such as Parkinson’s. CEO Alice Zhang explains how the platform works, why she believes it is superior to traditional approaches and the company’s plans for the future.

Go Top